Search for: "Janssen Pharmaceuticals Inc." Results 41 - 60 of 195
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Apr 2017, 9:58 pm by Patent Docs
Actavis Laboratories FL, Inc. et al. v Janssen Oncology, Inc. [read post]
18 Apr 2011, 1:12 pm by Mark Zamora
Ortho-McNeil Neurologics Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., today announced it is voluntarily recalling two lots of TOPAMAX® (topiramate) 100mg Tablets.   [read post]
29 Sep 2015, 4:45 am by briadm
The plaintiff, Sonja Lemoins, filed the 90-count complaint in Madison County, Illinois, against Janssen Pharmaceuticals, Inc., Bayer Corporation and several related companies. [read post]
13 Nov 2018, 4:17 pm by Jon L. Gelman
Grewal announced today that the State has submitted for filing a five-count lawsuit against Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson, for deceiving consumers about the dangers of two of the company’s opioid products with high potential for abuse – Nucynta and Nucynta ER. [read post]
11 Sep 2008, 4:55 am
Forest Laboratories, Inc. and Merck & Co. v. [read post]
2 Sep 2020, 1:45 pm by Tom Lamb
The Defendants named in a typical lawsuit filed on behalf of an Elmiron user who developed vision problems might be some combination of the following: JANSSEN PHARMACEUTICALS, INC., f/k/a Ortho-McNeil-Janssen Pharmaceuticals, Inc., f/k/a Janssen Pharmaceutica Inc. [read post]
19 Apr 2021, 9:37 am by Deb Givens
Circuit Court of Appeals on Tuesday revived a proposed class action against Janssen’s Actelion Pharmaceuticals Ltd accusing the company of extending its patent monopoly on its pulmonary artery hypertension drug Tracleer past the patent’s expiration date. [read post]
13 Mar 2018, 7:20 am by Law Offices of Jeffrey S. Glassman
Janssen Pharmaceuticals Inc., et al was reversed in January in state court, specifically the Philadelphia Court of Common Pleas. [read post]
13 Mar 2018, 7:20 am by Law Offices of Jeffrey S. Glassman
Janssen Pharmaceuticals Inc., et al was reversed in January in state court, specifically the Philadelphia Court of Common Pleas. [read post]
4 Nov 2013, 9:56 pm by Jon Gelman
”J&J Subsidiary Janssen Pleads Guilty to Misbranding Antipsychotic DrugIn a criminal information filed today in the Eastern District of Pennsylvania, the government charged that, from March 3, 2002, through Dec. 31, 2003, Janssen Pharmaceuticals Inc., a J&J subsidiary, introduced the antipsychotic drug Risperdal into interstate commerce for an unapproved use, rendering the product misbranded. [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
(patent infringement) 1/8: Alza Corporation and Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
18 Feb 2011, 11:00 am by Bottar Leone, PLLC
An Ortho-MacNeil affiliate, Ortho-MacNeil-Janssen Pharmaceuticals, Inc., will also pay more than $75,000,000.00 to resolve civil allegations under the False Claims Act for improper Topamax promotion. [read post]
24 Nov 2014, 2:15 pm by Tom Lamb
Recently Revised Topamax Label Includes Data Of 2014 Annual Report From The North American Antiepileptic Drug (NAAED) Pregnancy Registry (Posted by Tom Lamb at DrugInjuryWatch.com) By means of an October 21, 2014 FDA letter to Janssen Pharmaceuticals, Inc. [read post]